Company Filing History:
Years Active: 2016
Title: Lázaro Gil González: Innovator in Vaccine Development
Introduction
Lázaro Gil González is a notable inventor based in Mayabeque, Cuba. He has made significant contributions to the field of vaccine development, particularly in relation to the dengue virus. His innovative work has the potential to impact public health positively.
Latest Patents
Lázaro Gil González holds a patent for a dengue virus vaccine composition. This vaccine comprises at least one antigen based on the dengue virus (DV) capsid protein and the oligonucleotide identified as SEQ ID NO 1. The composition includes a fusion protein formed by the DV2 capsid and domain III of the envelope protein of the same serotype. This formulation has demonstrated higher levels of cellular immune response and protection in mice compared to previous formulations. The efficacy of these compositions has also been validated in non-human primates. The vaccine compositions can be monovalent, bivalent, or tetravalent and are designed to induce a functional immune response to the four viral serotypes.
Career Highlights
Throughout his career, Lázaro has worked with prominent institutions such as the Centro de Ingeniería Genética y Biotecnología. His research and innovations have positioned him as a key figure in the field of biotechnology and vaccine development.
Collaborations
Lázaro has collaborated with Alienys Izquierdo Oliva, contributing to advancements in vaccine research and development.
Conclusion
Lázaro Gil González is a pioneering inventor whose work in dengue virus vaccine composition showcases his commitment to improving public health through innovative solutions. His contributions are vital in the ongoing fight against infectious diseases.